A Population-Based Analysis of the Risk of Glomerular Disease Relapse after COVID-19 Vaccination.

Mark CanneyMohammad AtiquzzamanAmanda M CunninghamYuyan ZhengLee ErSteven HawkenYinshan ZhaoSean J Barbour

Published in: Journal of the American Society of Nephrology : JASN (2022)

In a population-level cohort of patients with glomerular disease, a second or third dose of COVID-19 vaccine was associated with higher relative risk but low absolute increased risk of relapse.

Keyphrases

coronavirus disease
sars cov
diabetic nephropathy
high glucose
respiratory syndrome coronavirus